Page last updated: 2024-10-21

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Muscle Spasticity

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid has been researched along with Muscle Spasticity in 1 studies

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid: RN given refers to (S-(R*,R*-(E,E,Z,Z)))-isomer

Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Willemsen, MA1
IJlst, L1
Steijlen, PM1
Rotteveel, JJ1
de Jong, JG1
van Domburg, PH1
Mayatepek, E1
Gabreëls, FJ1
Wanders, RJ1

Reviews

1 review available for 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Muscle Spasticity

ArticleYear
Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Brain : a journal of neurology, 2001, Volume: 124, Issue:Pt 7

    Topics: Adolescent; Adult; Aldehyde Oxidoreductases; Brain; Cells, Cultured; Cerebrospinal Fluid; Child; Chi

2001